Constarium
← Search

Data · dataset · 2026

Study on the Efficacy of EMP in Improving Anemia and Long-Term Cardiovascular Prognosis in Hemodialysis Patients

Listed in ScienceDB

This study evaluated the efficacy of hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), recombinant human erythropoietin (rHuEPO), and polyethylene glycolated synthetic peptide erythropoietin analog (EMP) in patients with renal anemia undergoing maintenance hemodialysis.

Links

Where it is published

Catalogue records · 1

Topics

Provenance · 1 source records, 10 field assertions
SourceKeyLast seenRaw
ScienceDB10.57760/sciencedb.3754710 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · scidb cnconnector:scidb_cn@1.0.0
concepts[field].local:field:earth-environmentalmapping · scidb cnconnector:scidb_cn@1.0.0
concepts[field].local:field:engineeringmapping · scidb cnconnector:scidb_cn@1.0.0
concepts[field].local:field:humanitiesmapping · scidb cnconnector:scidb_cn@1.0.0
concepts[field].local:field:life-sciencesmapping · scidb cnconnector:scidb_cn@1.0.0
concepts[field].local:field:social-sciencemapping · scidb cnconnector:scidb_cn@1.0.0
descriptionsource · scidb cnconnector:scidb_cn@1.0.0/metadata/dc/description
license_textsource · scidb cnconnector:scidb_cn@1.0.0
publication_datesource · scidb cnconnector:scidb_cn@1.0.0
titlesource · scidb cnconnector:scidb_cn@1.0.0/metadata/dc/title